Drug Brings New Hope to Lung Cancer Patients

November 15, 2010


An ABC6 story profiles lung cancer patients who are taking part in an Abramson Cancer Center trial for the drug crizotinib, which targets a gene that promotes tumor growth, typically among younger, non-smoking patients. The patients in the story say they have seen dramatic responses -- tumor shrinkage as well as a reduction in symptoms like coughing... Read More

Related Information